| Results summary | View all lists in GO:BiolProc | View all genes in S01BA.profile.ud50 |
|
A biological process whose specific outcome is the progression of an integrated living unit: a cell, tissue, organ, or organism over time from an initial condition to a later condition. enrichment: 1.43-fold |
![]() |
||||||||||||
| Probe ID | Name | G | T | D | X | E | P | R | C | S | Description | ||
| 218502_S_AT | TRPS1 | T | D | R | trichorhinophalangeal syndrome I | ||||||||
| 215073_S_AT | NR2F2 | D | E | R | S | nuclear receptor subfamily 2, group F, member 2 | |||||||
| 206459_S_AT | WNT2B | D | S | wingless-type MMTV integration site family, member 2B | |||||||||
| 210538_S_AT | BIRC3 | G | S | baculoviral IAP repeat-containing 3 | |||||||||
| 203140_AT | BCL6 | G | D | X | R | C | S | B-cell CLL/lymphoma 6 (zinc finger protein 51) | |||||
| 213139_AT | SNAI2 | D | R | C | snail homolog 2 (Drosophila) | ||||||||
| 217997_AT | PHLDA1 | G | pleckstrin homology-like domain, family A, member 1 | ||||||||||
| 205116_AT | LAMA2 | D | C | laminin, alpha 2 (merosin, congenital muscular dystrophy) | |||||||||
| 201449_AT | TIA1 | G | P | TIA1 cytotoxic granule-associated RNA binding protein | |||||||||
| 214439_X_AT | BIN1 | G | T | D | bridging integrator 1 | ||||||||
| 217427_S_AT | HIRA | D | R | HIR histone cell cycle regulation defective homolog A (S. cerevisiae) | |||||||||
| 209357_AT | CITED2 | D | R | S | Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 | ||||||||
| 205945_AT | IL6R | G | D | X | S | interleukin 6 receptor | |||||||
| 213179_AT | RQCD1 | RCD1 required for cell differentiation1 homolog (S. pombe) | |||||||||||
| 209185_S_AT | IRS2 | G | D | E | S | insulin receptor substrate 2 | |||||||
| 203373_AT | SOCS2 | G | S | suppressor of cytokine signaling 2 | |||||||||
| 217996_AT | PHLDA1 | G | pleckstrin homology-like domain, family A, member 1 | ||||||||||
| 207675_X_AT | ARTN | G | D | S | artemin | ||||||||
| 207980_S_AT | CITED2 | D | R | S | Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 | ||||||||
| 203542_S_AT | KLF9 | D | R | S | Kruppel-like factor 9 | ||||||||
| 219049_AT | CHGN | ||||||||||||
| 200878_AT | EPAS1 | D | X | R | S | endothelial PAS domain protein 1 | |||||||
| 201502_S_AT | NFKBIA | G | T | D | S | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha | |||||||
| 201324_AT | EMP1 | G | D | epithelial membrane protein 1 | |||||||||
| 204924_AT | TLR2 | G | X | S | toll-like receptor 2 | ||||||||
| 201341_AT | ENC1 | D | ectodermal-neural cortex (with BTB-like domain) | ||||||||||
| 209120_AT | NR2F2 | D | E | R | S | nuclear receptor subfamily 2, group F, member 2 | |||||||
| 209184_S_AT | IRS2 | G | D | E | S | insulin receptor substrate 2 | |||||||
| 201340_S_AT | ENC1 | D | ectodermal-neural cortex (with BTB-like domain) | ||||||||||
| 211833_S_AT | BAX | G | T | D | X | P | S | BCL2-associated X protein | |||||